2026 ICD-10-CM Diagnosis Code T36.7X2SPoisoning by antifungal antibiotics, systemically used, intentional self-harm, sequela

ICD-10-CM CodesS00–T88T36-T50T36

ICD-10-CM T36.7X2S
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

T36.7X2S is a billable ICD-10-CM diagnosis code for poisoning by antifungal antibiotics, systemically used, intentional self-harm, sequela. The 7th character S marks it as a sequela code, which reports a problem that remains after the original condition has resolved. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 922 through 923. The code is exempt from POA reporting. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Mental and substance use disorders; sequela; and Poisoning/toxic effect/adverse effects/underdosing, sequela.

Code Identity

ICD-10-CM Code
T36.7X2S
Billable Status
Yes — Valid for Submission
Code Describes
Poisoning by antifungal antibiotics, systemically used, intentional self-harm, sequela
Short Description
Poisoning by antifung antibiot, sys used, self-harm, sequela
Parent Code
Poisoning by antifungal antibiotics, systemically used, intentional self-harm

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT36Poisoning by, adverse effect of and underdosing of systemic antibiotics
This CodeT36.7X2SPoisoning by antifungal antibiotics, systemically used, intentional self-harm, sequela

Present on Admission (POA)Billing

T36.7X2S is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Amphotericin B overdose
  • Griseofulvin overdose
  • Intentional amphotericin B overdose
  • Intentional amphotericin B poisoning
  • Intentional griseofulvin overdose
  • Intentional griseofulvin poisoning
  • Intentional nystatin overdose
  • Intentional nystatin poisoning
  • Intentional trichomycin poisoning
  • Nystatin overdose
  • Poisoning by amphotericin B
  • Poisoning by griseofulvin
  • Poisoning by nystatin
  • Poisoning by trichomycin

Coding GuidelinesGuidance

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined). If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of systemic antibiotics (T36). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR MBD034
Mental and substance use disorders; sequela
Default principal diagnosis: inpatient Yes · outpatient Yes
CCSR INJ075
Poisoning/toxic effect/adverse effects/underdosing, sequela
Default principal diagnosis: inpatient No · outpatient No

Clinical InformationClinical

  • Amphotericin B

    macrolide antifungal antibiotic produced by streptomyces nodosus obtained from soil of the orinoco river region of venezuela.
  • Griseofulvin

    an antifungal agent used in the treatment of tinea infections.
  • Mepartricin

    polyene macrolide antibiotic with unknown composition. it is obtained from streptomyces aureofaciens. it is used as an antifungal agent, an antiprotozoal agent, and in the treatment of benign prostatic hypertrophy.
  • Nystatin

    macrolide antifungal antibiotic complex produced by streptomyces noursei, s. aureus, and other streptomyces species. the biologically active components of the complex are nystatin a1, a2, and a3.

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect
Under­dosing
Amphotericin BT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
Amphotericin B::topicalT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
AntifungalT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
Antifungal::antibiotic (systemic)T36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
Antifungal::anti-infective NECT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
Antifungal::disinfectant, localT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
Antifungal::nonmedicinal (spray)T36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
Antifungal::topicalT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
FulvicinT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
FungizoneT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
Fungizone::topicalT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
GrifulvinT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
GriseofulvinT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
HachimycinT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
MepartricinT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
MycostatinT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
Mycostatin::topicalT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
NilstatT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
Nilstat::topicalT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
NystatinT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
Nystatin::topicalT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
PimaricinT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6
TrichomycinT36.7X1T36.7X2T36.7X3T36.7X4T36.7X5T36.7X6

Patient EducationClinical

Antibiotics

Antibiotics are medicines that fight bacterial infections in people and animals. They work by killing the bacteria or by making it hard for the bacteria to grow and multiply.

The full article covers:

  • What are antibiotics?
  • What do antibiotics treat?
  • Do antibiotics treat viral infections?
  • What are the side effects of antibiotics?
  • Why is it important to take antibiotics only when they're needed?
  • How do I use antibiotics correctly?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T36.7X2S to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
909.0 Late eff drug poisoning
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E959 Late eff of self-injury
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About T36.7X2SOverview

Is T36.7X2S a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report poisoning by antifungal antibiotics, systemically used, intentional self-harm, sequela on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What does the 7th character S in T36.7X2S mean?

The final character S makes this a sequela code: it reports a lingering problem that remains after the poisoning by antifungal antibiotics, systemically used, intentional self-harm itself has resolved, not the original event.

What MS-DRG does T36.7X2S group to?

When poisoning by antifungal antibiotics, systemically used, intentional self-harm, sequela is the principal diagnosis on an inpatient stay, it groups to MS-DRG 922, 923, with relative weights from 1.0177 to 1.7494 depending on complications. Higher weights mean higher Medicare reimbursement.

Is T36.7X2S exempt from POA reporting?

Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for poisoning by antifungal antibiotics, systemically used, intentional self-harm, sequela on inpatient claims.

What is the ICD-9 equivalent of T36.7X2S?

Under the General Equivalence Mappings, poisoning by antifungal antibiotics, systemically used, intentional self-harm, sequela converts to ICD-9-CM 909.0 (late eff drug poisoning) and E959 (late eff of self-injury). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.